| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |